Rehmannia glutinosa (Di Huang): Blood tonic in traditional Chinese medicine and scientific validation

Rehmannia glutinosa (Gaertn.) DC., known by its Chinese name Di Huang (地黄), is one of the most important medicinal plants in traditional Chinese medicine. Classified as a major blood tonic (补血药, Bu Xue Yao), this plant from the Orobanchaceae family has been used for over 2,000 years to treat various conditions related to blood deficiency. This article examines the theoretical basis for its use in traditional Chinese medicine, its phytochemical composition, its biological mechanisms of action, and contemporary clinical data validating its hematopoietic and neuroprotective properties.

Introduction

Traditional Chinese medicine (TCM) conceptualizes blood not only as a bodily fluid but also as a vital substance (精, Jing) that nourishes the organs and tissues. Blood deficiency (血虚, Xue Xu) manifests with symptoms including pallor, dizziness, palpitations, insomnia, and menstrual irregularities. Rehmannia glutinosa occupies a central position in the treatment of these imbalances, appearing in classic formulas such as Si Wu Tang (四物汤) and Liu Wei Di Huang Wan (六味地黄丸).

The plant exists in three distinct prepared forms: Sheng Di Huang (fresh root), Gan Di Huang (dried root), and Shu Di Huang (root prepared by repeated boiling in wine). Each form possesses specific therapeutic properties, with Shu Di Huang considered the most potent for tonifying the blood and nourishing Kidney Yin.

Phytochemical Composition

Modern phytochemical research has identified over 140 bioactive compounds in R. glutinosa. The main classes of molecules include:

Iridoid glycosides

Iridoids are the characteristic chemical markers of the plant. Catalpol, present at concentrations of 0.2 to 3% depending on the preparation, is the most studied compound. Other important iridoids include aucubin, rehmannioside A, B, C, and D, as well as leonuride. These molecules exhibit significant anti-inflammatory, antioxidant, and neuroprotective activities.

Polysaccharides

Rehmannia polysaccharides (RPS) constitute approximately 3 to 5% of the dry weight of the prepared root. These complex macromolecules, composed mainly of glucose, galactose, arabinose, and rhamnose, demonstrate immunomodulatory and hematopoietic properties. Studies have shown that RPS stimulate the proliferation of hematopoietic stem cells and regulate the differentiation of myeloid and lymphoid lineages.

Other components

The plant also contains phenolic acids (chlorogenic acid, caffeic acid), phenylethanoids (acteoside, echinacoside), simple sugars (stachyose, raffinose, mannitol), and various amino acids. Traditional preparation by repeated cooking with wine significantly alters the chemical profile, increasing Maillard reaction products and decreasing iridoids, which could explain the differences in therapeutic activity between Sheng Di Huang and Shu Di Huang.

Mechanisms of action on hematopoiesis Stimulation of erythropoiesisSeveral experimental studies have confirmed the hematopoietic properties of R. glutinosa.

Zhang et al. demonstrated that extracts of Shu Di Huang stimulate erythropoietin (EPO) production in vitro and in vivo, significantly increasing hemoglobin levels and erythrocyte count in anemic mouse models. Catalpol specifically activates the JAK2-STAT5 signaling pathway, which is crucial for erythroid differentiation.

A study by Li and his team revealed that Rehmannia polysaccharides promote the proliferation of human CD34+ hematopoietic stem cells in vitro, increasing their number 2.3-fold compared to the control group. These polysaccharides also stimulate the secretion of hematopoietic growth factors, including GM-CSF (granulocyte-macrophage colony-stimulating factor) and IL-3 (interleukin-3).

Bone Marrow Protection Research in chemotherapy-induced myelosuppression models has shown that R. glutinosa exerts significant protective effects on the bone marrow. Administration of Rehmannia extracts before and during cyclophosphamide treatment reduces leukopenia, thrombocytopenia, and anemia in rats. The mechanisms involved include the reduction of bone marrow oxidative stress, the inhibition of hematopoietic stem cell apoptosis, and the modulation of the expression of genes regulating the cell cycle.

Neuroprotective and Anti-Aging Activities Beyond its hematological effects,

R. glutinosa

demonstrates robust neuroprotective properties, consistent with its traditional use to nourish Kidney Yin and enhance cognitive function. Catalpol protects neurons against various stressors, including cerebral ischemia, glutamate toxicity, and beta-amyloid accumulation. In mouse models of Alzheimer’s disease, catalpol improves cognitive performance, reduces amyloid plaque formation, and attenuates neuroinflammation via inhibition of the NF-κB pathway. These effects also involve the activation of neurotrophic factors such as BDNF (brain-derived neurotrophic factor). Studies on aging have revealed that

R. glutinosa

It modulates the hypothalamic-pituitary-adrenal (HPA) axis and increases the activity of antioxidant enzymes such as superoxide dismutase (SOD) and glutathione peroxidase. In aged rats, chronic administration of Rehmannia extracts improves spatial memory and preserves the structural integrity of the hippocampus.

Immunomodulatory and Anti-inflammatory Effects Rehmannia polysaccharides exert biphasic immunomodulatory effects: immunostimulatory at low doses and immunosuppressive at high doses. They activate macrophages, increase phagocytosis, and stimulate the production of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) under immunosuppressive conditions.

Paradoxically, in contexts of excessive inflammation, R. glutinosa

demonstrates anti-inflammatory properties. Catalpol inhibits the production of inflammatory mediators by suppressing the activation of NF-κB and the MAPK pathway. These anti-inflammatory effects likely contribute to the benefits observed in autoimmune diseases and chronic inflammatory conditions.

Clinical Studies

Despite millennia of traditional use, rigorous clinical trials on R. glutinosa alone remain limited, as the plant is generally used in complex formulations. Anemia

A controlled clinical study conducted in China on 120 patients with iron deficiency anemia compared standard treatment (ferrous sulfate) to a combination of ferrous sulfate and Shu Di Huang extract. The group receiving the combination showed significantly greater improvement in hematological parameters (hemoglobin, hematocrit, serum ferritin) after 8 weeks of treatment, with better gastrointestinal tolerance.

Age-related cognitive dysfunction

A pilot trial involving 60 older adults with mild cognitive decline evaluated the efficacy of a formula containing R. glutinosa as the main ingredient (40% of the formula). After 12 weeks, the treated group showed significant improvements in cognitive tests (MMSE, MoCA) compared to the placebo group, with no notable adverse effects.

Nephrotic Syndrome

Chinese clinical studies have reported that Rehmannia-based formulas reduce proteinuria and improve renal function in patients with chronic nephropathy. These effects are thought to be mediated by anti-inflammatory, antioxidant, and antiproteinuric properties.

Safety and Adverse Effects

Rehmannia glutinosa is generally considered safe at traditional therapeutic doses (9–30 g of dried root per day). Reported adverse effects are rare and mainly include mild digestive disturbances (bloating, diarrhea) in individuals with poor digestion, consistent with the TCM concept that Di Huang is “slippery” in nature and can impede the Spleen.

Acute and subacute toxicity studies in animals have revealed no significant toxicity at doses up to 100 times the human therapeutic dose. No mutagenic, genotoxic, or carcinogenic effects were identified in standard tests.

However, due to its potential effects on steroid hormones and thyroid function observed in some animal studies, caution is advised in pregnant or breastfeeding women, and in individuals undergoing hormone therapy.

Perspectives and Challenges

Although modern research is gradually validating the therapeutic properties of R. glutinosa

Several challenges remain. Standardizing preparations is still problematic, with considerable variability in chemical composition depending on geographic origin, harvest time, and processing methods. The traditional preparation process of Shu Di Huang, involving nine cycles of cooking and drying with wine, is particularly difficult to standardize.

The precise molecular mechanisms explaining the synergy between the plant’s multiple components require further elucidation. The reductionist approach of modern pharmacology, focused on isolating single compounds, may not fully capture the complexity of the therapeutic effects of a plant traditionally used as a whole extract.

---

Multicenter, randomized, double-blind clinical trials with rigorous methodologies are needed to definitively establish the efficacy of R. glutinosa in specific indications according to evidence-based medicine standards. Integrating the diagnostic and therapeutic paradigms of Traditional Chinese Medicine (TCM) with contemporary research methodologies represents a significant but essential methodological challenge. Conclusion

1. Rehmannia glutinosa (Di Huang) illustrates the potential of traditional Chinese medicine as a source of scientifically validated therapeutic agents. Contemporary pharmacological and clinical data confirm its hematopoietic, neuroprotective, and immunomodulatory properties, consistent with its millennia-old traditional use as a blood tonic and Yin nourisher. Iridoids, particularly catalpol, and polysaccharides are the main bioactive constituents, acting via multiple molecular pathways including stimulation of erythropoiesis, protection against oxidative stress, immune modulation, and neuroprotection. These findings open promising avenues for the development of complementary therapies for anemia, neurodegenerative diseases, and chronic inflammatory syndromes.Further research, combining ethnopharmacological, phytochemical, pharmacological, and clinical approaches, will allow for a better characterization of the therapeutic potential of this remarkable plant and its appropriate integration into the contemporary therapeutic arsenal.
2. ReferencesZhang RX, Li MX, Jia ZP. Rehmannia glutinosa: review of botany, chemistry and pharmacology.
3. Journal of Ethnopharmacology 2008;117(2):199-214.
4. Li J, Huang W, Zhang H, Wang X, Zhou H. Synthesis of Rehmannia glutinosa polysaccharides and their immunological activity. International Journal of Biological Macromolecules. 2010;47(5):573-576.
5. Park CH, Yamabe N, Noh JS, Kang KS, Tanaka T, Yokozawa T. The beneficial effects of Morroniside on the inflammatory response and lipid metabolism in the liver of db/db mice. Biological and Pharmaceutical Bulletin. 2009;32(10):1734-1740.
6. Xu DH, Zhao L, Xu JJ, Wang Y, Li ZB. Effects of catalpol on hematopoietic function in cyclophosphamide-induced mice. Zhongguo Zhong Yao Za Zhi. 2012;37(22):3395-3399.
7. Wang J, Zhang Y, Liu X, et al. Catalpol ameliorates cognitive deficits and attenuates oxidative damage in senescent mice induced by D-galactose. Pharmacology Biochemistry and Behavior. 2013;103(4):693-700.
8. Kwon SH, Ma SX, Hong SI, et al. Catalpol attenuates memory impairment via anti-inflammatory and neuroprotective effects in an Alzheimer’s disease mouse model. Toxicology and Applied Pharmacology. 2018;357:21-29.
9. Jiang Y, Tu PF. Analysis of chemical constituents in Rehmannia glutinosa. Journal of Chromatography. 2009;1216(11):1954-1969.
10. Lee B, Sur B, Park J, Kim SH, Kwon S, Yeom M, Shim I, Lee H, Hahm DH. Ginsenoside Rg3 alleviates lipopolysaccharide-induced learning and memory impairments by anti-inflammatory activity in rats. Biomolecules & Therapeutics. 2013;21(5):381-390.
11. Kim HY, Kim HK, Kwon JH, et al. Neuroprotective effect of Rehmannia glutinosa on scopolamine-induced memory impairment in rats. Korean Journal of Oriental Physiology & Pathology. 2005;19(3):645-651.
12. Zhou YX, Zhang H, Peng C. Effects of Rehmannia glutinosa on hematopoietic recovery in irradiated mice. Chinese Journal of Integrated Traditional and Western Medicine. 2007;27(5):445-448.
13. Chao J, Lau WK, Huie MJ, et al. A pro-drug of the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) prevents differentiation of murine bone marrow-derived dendritic cells. Journal of Pharmacology and Experimental Therapeutics. 2009;331(2):636-644.
14. Kitagawa I, Sakagami M, Hashiuchi F, et al. Structure and hepatoprotective activity of rehmaionosides from Chinese Rehmannia glutinosa. Yakugaku Zasshi. 1998;118(11):593-604.
15. Sun L, Wang Y, Song Y, Cheng XR, Xia S, Rahman K, Zhang H, Qin Y. Resveratrol restores the circadian rhythmic disorder of lipid metabolism induced by high-fat diet in mice. Biochemical and Biophysical Research Communications. 2015;458(1):86-91.
16. Yang M, Xu DD, Zhang Y, et al. A water-soluble extract from Rehmannia glutinosa exhibits anti-inflammatory effects by regulating NF-κB and MAPK pathways. BMC Complementary and Alternative Medicine. 2014;14:377.
17. Yokozawa T, Yamabe N, Kim HY, et al. Protective effects of magnesium lithospermate B against diabetic nephropathy in rats. Journal of Pharmacy and Pharmacology. 2004;56(10):1379-1388.
18. Chinese Pharmacopoeia Commission. Pharmacopoeia of the People’s Republic of China. Flight. 1. Beijing: China Medical Science Press; 2020:140-141.
19. Bensky D, Gamble A, Kaptchuk T. Chinese Herbal Medicine: Materia Medica. 3rd ed. Seattle: Eastland Press; 2004:756-762.
20. Yuan B, Yang R, Ma Y, Zhou S, Zhang X, Liu Y. A systematic review of the active constituents and pharmacological effects of Rehmannia glutinosa Libosch. Evidence-Based Complementary and Alternative Medicine. 2017;2017:5367402.